Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.
about
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@en
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@nl
type
label
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@en
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@nl
altLabel
Cannabinoid CB1 and CB2 Recept ...... ients with Parkinson’s Disease
@en
prefLabel
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@en
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@nl
P2860
P50
P921
P1433
P1476
Cannabinoid CB1 and CB2 Recept ...... ents with Parkinson's Disease.
@en
P2860
P2888
P304
P356
10.1007/S13311-018-0603-X
P4011
e419f65a9dade86512436bb4f303e2c98eb482b3
P407
P577
2018-01-19T00:00:00Z